Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology GroupShalini C. Reshmi, Stephen P. Hunger, Amy Smith et al.|Blood|2017Cited by 305
<i>ATM</i> germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Kjeld Schmiegelow, Ruth Shiloh et al.|Blood|2024Cited by 24